Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is primary cns lymphoma?
Primary central nervous system (CNS) lymphoma is an uncommon, aggressive lymphoma — a cancer of immune system cells — that begins in and stays confined to the central nervous system: the brain, spinal cord, the membranes covering them, and the eyes. Although it is a lymphoma rather than a typical brain tumor, it grows within the brain and is treated very differently from cancers like glioblastoma. Most cases are a subtype called diffuse large B-cell lymphoma. Symptoms come from where the lymphoma sits in the brain and may include changes in thinking or memory, personality or behavior changes, weakness or numbness, trouble with balance or speech, headaches, or vision problems if the eyes are involved. The disease is more common in older adults and in people whose immune systems are weakened. Because the brain is protected by a natural barrier that keeps many drugs out, ordinary lymphoma chemotherapy does not work well; instead, treatment centers on special high-dose chemotherapy (built around a drug called methotrexate) that can cross into the brain. Radiation, which the disease is very sensitive to, was once a mainstay but is now used more selectively — for example, to consolidate a chemotherapy response, when chemotherapy cannot be given, or to relieve symptoms — because of concerns about long-term effects on thinking, especially in older patients. Care is coordinated by a team of neuro-oncologists, hematologist-oncologists, and radiation oncologists.
The main types
Doctors group primary cns lymphoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Diffuse large B-cell lymphoma of the CNS | The most common form by far — an aggressive B-cell lymphoma confined to the brain, spinal cord, or coverings; it responds to high-dose methotrexate-based chemotherapy and to radiation. |
| Primary intraocular (eye) lymphoma | Lymphoma involving the eyes, which can occur with or before brain involvement; it may cause blurred vision or floaters and is treated as part of CNS lymphoma. |
| Immunodeficiency-associated CNS lymphoma | A form that occurs in people with weakened immune systems; treatment also focuses on restoring immune function when possible. |
Staging, in plain terms
Primary CNS lymphoma is not staged with the TNM system used for solid tumors, because by definition it stays within the central nervous system. Instead of a stage number, the team performs an evaluation to map exactly where the lymphoma is and to confirm it has not started elsewhere in the body. This work-up typically includes an MRI of the brain (and sometimes the spine), an eye examination to check for involvement, and a sampling of the spinal fluid to look for lymphoma cells; a biopsy confirms the diagnosis. Doctors also assess a patient's age and overall function, because these strongly influence how intensive treatment can be and the risk of long-term effects. This careful mapping — rather than a stage number — guides whether treatment targets the brain alone or must also address the eyes or spinal fluid, and how radiation and chemotherapy are combined.
| No standard TNM — assessed by extent within the nervous system and eyes | What it generally means |
|---|---|
| Brain-only disease | Lymphoma confined to the brain tissue; treated with high-dose chemotherapy that crosses into the brain, with radiation considered for consolidation or if chemotherapy is not an option. |
| Disease with eye or spinal-fluid involvement | Lymphoma also affecting the eyes or the fluid around the brain and spine; treatment is broadened to reach these areas, sometimes including radiation to the eyes. |
| Relapsed or refractory disease | Lymphoma that returns or does not respond to initial treatment; options include radiation, different chemotherapy, or newer approaches, often within a clinical trial. |
The standard of care
Primary CNS Lymphoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
High-dose methotrexate-based chemotherapy
The foundation of treatment is high-dose chemotherapy built around methotrexate, a drug that can cross the brain's protective barrier; it is usually combined with other agents to maximize the response.
Consolidation therapy
After the initial chemotherapy shrinks the lymphoma, additional treatment — which may be more chemotherapy, a stem-cell transplant, or radiation — is given to deepen and prolong the remission.
Radiation therapy
Because the lymphoma is very radiation-sensitive, radiation to the whole brain can be highly effective; it is now used selectively — for consolidation, when chemotherapy cannot be given, or to relieve symptoms — often at reduced doses to protect thinking.
Treatment of eye involvement
When the eyes are affected, treatment is adjusted to reach them, which may include radiation to the eyes or medication placed into the eye.
Supportive and neurologic care
Close attention to neurologic symptoms, steroids to reduce brain swelling, and cognitive support are important parts of care given the disease's location in the brain.
How radiation treatment works
Radiation uses focused high-energy beams to damage the DNA inside cancer cells so they can no longer grow and divide. Primary CNS lymphoma is very sensitive to radiation, which is why radiation was historically a mainstay and remains a powerful tool. Because the lymphoma tends to spread microscopically through the brain rather than staying in one spot, radiation is usually directed at the whole brain rather than a single area. The challenge is that radiation to the whole brain — especially at the higher doses used in the past — can affect memory and thinking over time, particularly in older adults, who make up many patients with this disease. For that reason, modern treatment leads with high-dose chemotherapy that crosses into the brain, and uses radiation more selectively: as consolidation after chemotherapy (often at a reduced dose to protect cognition), when chemotherapy cannot be given safely, to treat the eyes when they are involved, or to relieve symptoms quickly. Advanced planning techniques can also spare memory-related regions of the brain. Treatment is given as a series of short daily sessions, and the dose and target are tailored to the goal of care and the patient's age and overall health. Your radiation and neuro-oncology team will balance the strong effectiveness of radiation against protecting long-term brain function.
The main ways radiation is delivered for primary cns lymphoma:
Whole-brain radiation therapy
Because the lymphoma can seed throughout the brain microscopically, radiation is often directed to the whole brain rather than a single spot; this controls the disease broadly, and modern practice favors lower doses to reduce effects on memory and thinking.
Reduced-dose consolidation radiation
After chemotherapy achieves a good response, a lower dose of whole-brain radiation can consolidate the remission while limiting the long-term cognitive side effects seen with older, higher-dose radiation.
Radiation to the eyes
When lymphoma involves the eyes, targeted radiation can treat them effectively, either alongside brain treatment or for eye-only disease.
Hippocampal-sparing techniques
Advanced planning can reduce dose to memory-related brain regions during whole-brain radiation, aiming to lower the impact on memory and thinking.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Chemotherapy-first strategies: Research established high-dose methotrexate-based chemotherapy as the foundation of treatment, allowing radiation to be reduced or delayed to protect thinking while maintaining strong disease control.[1]
Primary CNS lymphoma chemotherapy trials
Reduced-dose consolidation radiation: Studies showed that lowering the dose of whole-brain radiation after a good chemotherapy response can maintain control while substantially reducing long-term effects on memory and thinking.[2]
Reduced-dose radiation consolidation studies
Newer drugs and transplant for consolidation: Trials of targeted drugs, immune-based therapies, and autologous stem-cell transplant are expanding consolidation options, sometimes avoiding radiation entirely in fit patients.[3]
CNS lymphoma consolidation research
Common questions
Is this a brain tumor or a lymphoma? It is a lymphoma — a cancer of immune cells — that happens to begin in and stay within the brain, spinal cord, or eyes. That distinction matters, because it is treated very differently from typical brain tumors, relying mainly on special chemotherapy that can reach the brain, with radiation used selectively.
Why isn't radiation always used first if the cancer is so radiation-sensitive? The lymphoma responds strongly to radiation, but whole-brain radiation — especially at older, higher doses — can affect memory and thinking over time, particularly in older adults. Leading with chemotherapy and using radiation more selectively, at reduced doses, helps preserve long-term brain function while still controlling the disease.
Will treatment affect my memory or thinking? It can, especially with whole-brain radiation, which is why modern treatment uses lower doses, memory-sparing techniques, and chemotherapy-first approaches to reduce this risk. Your team will weigh these effects against the need to control the lymphoma and will monitor your cognition during and after treatment.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.